Home › Compare › AXXTF vs ABBV
AXXTF yields 3.39% · ABBV yields 3.06%● Live data
📍 AXXTF pulled ahead of the other in Year 5
Combined, AXXTF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AXXTF + ABBV for your $10,000?
Axiata Group Berhad, an investment holding company, provides telecommunications services in Asia. The company provides mobile services and other services, such as provision of interconnect services, sale of devices, pay television transmission, and broadband services; and telecommunication infrastructure and related services. The company also offers telecommunication network capacity; international carrier and enterprise; technical and operations support; media and digital; software development; multimedia; data and backbone and fixed wireless; television broadcasting and direct-to home satellite pay television; and financial services, as well as commerce distribution business and rendering solutions. In addition, it is involved in the provision of services related to IT; venture capital funding; network development, operations, and maintenance; digital credit facilities; software licensing; e-learning content; and trading and distribution of communication devices and goods, as well as managing retail stores. Further, the company provides e-commerce and digital marketing; fiber optic transmission networks; multimedia advertising; online ticketing; micro-financing and insurance, and money lending; e-wallet mobile application; and data processing and management consultation services, as well as mobile virtual network enabler platforms, and marketable securities. Additionally, it is also involved in the property development and letting of property for commercial purposes; sale of IT enabled equipment; provision of manpower for call center operations; development and operation of electronic commerce infrastructure for the healthcare sector; provision of IT, information, and communications technology services to nonmobile network operator business activities. The company was formerly known as TM International Berhad and changed its name to Axiata Group Berhad in March 2009. Axiata Group Berhad was incorporated in 1992 and is headquartered in Kuala Lumpur, Malaysia.
Full AXXTF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.